Genetic Technologies Ltd - American Depositary Shares (GENE) Covered Calls

Genetic Technologies Ltd - American Depositary Shares covered calls Genetic Technologies Ltd. is a biotechnology company focuses on expanding its genetic testing and reproductive service businesses in the Asia-Pacific region.

You can sell covered calls on Genetic Technologies Ltd - American Depositary Shares to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for GENE (prices last updated Tue 1:45 PM ET):

Genetic Technologies Ltd - American Depositary Shares (GENE) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
2.40 +0.03 2.36 2.39 9K - 0.0
Covered Calls For Genetic Technologies Ltd - American Depositary Shares (GENE)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
May 17 2.5 0.05 2.34 2.1% 30.7%
Jun 21 2.5 0.20 2.19 9.1% 55.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Genetic Technologies Ltd. engages in the business of genetic testing services. The company performs a variety of genetic tests on humans and animals which includes human diagnostics, forensics and animal pedigree tests. It operates through the following segments: Operations, Licensing and Research. The Operations segment involves the provision of a range of genetic testing services. The Licensing segment involves the out-licensing of its intellectual property relating to non-coding DNA technology. The Research segment involves the undertaking of a range of research and development projects in the field of genetics and related areas. Genetic Technologies was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.